Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Bcr-Abl
    (2)
  • Apoptosis
    (1)
  • FLT
    (1)
  • Src
    (1)
  • Others
    (1)
Filter
Search Result
Results for "

abl1t315i

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    3
    TargetMol | Inhibitors_Agonists
Rebastinib
DCC-2036, DCC2036, DCC 2036
T26401020172-07-9
DCC-2036 (Rebastinib (DCC-2036)) is a conformational control Bcr-Abl inhibitor for Abl1(WT, IC50: 0.8 nM) and Abl1(T315I, IC50: 4 nM), also inhibits LYN, SRC, HCK, FGR, FLT3, KDR, and Tie-2, and low activity to c-Kit. Rebastinib aimed at the Angiopoietin2-Tie2 pathway.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
BCR-ABL-IN-2
T10489897369-18-5
BCR-ABL-IN-2 is a BCR-ABL1 tyrosine kinase inhibitor (IC50s: 57 nM, 773 nM for ABL1 native and ABL1 T315I).
  • Inquiry Price
6-8 weeks
Size
QTY
Vodobatinib
K-0706
T88821388803-90-4
Vodobatinib (K-0706) is a novel 3rd generation (3G) TKI effective against wild-type and mutated BCR-ABL1 with limited off-target activity.
  • Inquiry Price
Size
QTY